Amoeba SA (FR:ALMIB) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Koppert, a leader in biological crop protection, and Amoéba, a greentech company, have signed a Memorandum of Understanding to jointly launch a groundbreaking biofungicide named AXPERA. This partnership aims to enhance sustainable agriculture by utilizing Amoéba’s innovative amoeba-based solution to combat fungal diseases. The collaboration will focus on distribution, production, and regulatory approvals, with AXPERA expected to hit the European market by the end of 2025.
For further insights into FR:ALMIB stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ‘Get in for 2025 Gains,’ Says Cowen on Amazon Stock
- Top Analyst Sets the Stage for Nike Stock Ahead of Earnings
- Class Action Lawsuit Against Terran Orbital Corporation (LLAP)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
